Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
破译代码：理解神经分泌生物科学的分析师评论
Analysts' ratings for Neurocrine Biosciences (NASDAQ:NBIX) over the last quarter vary from bullish to bearish, as provided by 16 analysts.
16位分析师提供的分析师对Neurocrine Biosciences（纳斯达克股票代码：NBIX）在上个季度的评级从看涨到看跌不等。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $167.94, a high estimate of $216.00, and a low estimate of $138.00. This upward trend is apparent, with the current average reflecting a 5.89% increase from the previous average price target of $158.60.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为167.94美元，最高估计为216.00美元，低估值为138.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价158.60美元上涨了5.89％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
A clear picture of Neurocrine...
通过对分析...
登录免费看全文
登录/注册